FIELD: medicine. SUBSTANCE: this method prescribes administering dimephosphone-dimethyl ether of 1,1-dimethyl-3-oxobutyl phosphonic acid in daily dose of 50 to 90 mg/kg body mass. Cures lasting from 10 to 20 days should be carried out at five-month intervals. EFFECT: disclosed method allows correcting intellectual-mnestic functions of encephalon in cases of disorders and states accompanied by memory disturbance and reduced mental productivity, in particular, certain kinds of mental dysontogenesis. 2 cl, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT POSSESSING NOOTROPIC ACTIVITY (VARIANTS) | 2006 |
|
RU2322240C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
| MEANS FOR CORRECTION OF CHOLINERGIC DISORDERS OF THE MNESTIC PROCESSES | 2017 |
|
RU2665970C1 |
| N-(5-HYDROXYNICOTINOYL)-L-GLUTAMIC ACID MONO- AND BIVALENT SALTS POSSESSING PSYCHOTROPIC (ANTIDEPRESSANT AND ANXIOLYTIC), NEUROPROTECTIVE, GEROPROTECTIVE AND ANTI-INSULT EFFECT | 2006 |
|
RU2314293C1 |
| COMPOSITION HAVING ACTION ON CENTRAL NERVOUS SYSTEM AND USING IT | 2013 |
|
RU2546300C1 |
| NEUROTROPIC DRUG AND METHOD FOR ITS PRODUCTION | 2007 |
|
RU2359962C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| GAMMA-AMINOBUTYRIC ACID DERIVATIVE, HAVING NOOTROPIC ACTIVITY COUPLED WITH TRANQUILISING ACTIVITY | 2012 |
|
RU2495866C1 |
| DILITHIUM SALT OF N-SALICYLOYL GLYCINE, HAVING NOOTROPIC ACTIVITY | 2012 |
|
RU2495867C1 |
| REMEDY POSSESSING ANTIAMNESTIC AND ANTIHYPOXIC ACTIVITY | 1991 |
|
RU2099055C1 |
